There were dose-dependent increases of BMI, waist circumference, SBP, DBP, fasting blood glucose (FBS), total cholesterol, triglyceride, and HSI and prevalence rates of diabetes mellitus and MS as the ALT levels increased in both male and female participants. The gene discussed is GPT; the disease is diabetes mellitus.